#192 Debate on First-Line Medications for Diabetes
Artikel konnten nicht hinzugefügt werden
Der Titel konnte nicht zum Warenkorb hinzugefügt werden.
Der Titel konnte nicht zum Merkzettel hinzugefügt werden.
„Von Wunschzettel entfernen“ fehlgeschlagen.
„Podcast folgen“ fehlgeschlagen
„Podcast nicht mehr folgen“ fehlgeschlagen
#192 Debate on First-Line Medications for Diabetes
-
Gesprochen von:
-
Von:
Über diesen Titel
SGLT-2i vs. GLP-1? vs Metformin? How do you balance the cost and coverage of first-line options like metformin, SGLT-2, and GLP-1s? How do you choose between SGLT-2 and GLP-1s for comorbidities like CAD or CKD? And how do you weigh their side effects and practical use?
🔹 Sponsor:
Use the code "CORE30" for 30% off: https://www.coreimpodcast.com/MKSAP
🔹 Transcript and Show Notes
Timestamps:
(01:43) | Case 1: Managing Uncontrolled Diabetes in a 47-Year-Old Male
(07:15) | Understanding Cost and Insurance Barriers in Diabetes Care
(09:26) | Case 2: Addressing Weight Gain and Financial Stress in a 52-Year-Old Male
(14:16) | Case 3: Managing Coronary Artery Disease and CKD in a 66-Year-Old Male
(19:41) | Case 4: Severe Obesity and Pain Management in a 59-Year-Old Female
(24:19) | Case 5: High A1C and Vascular Comorbidities in a 67-Year-Old Female
(35:34) | Weighing Side Effects and Practical Use of GLP-1 and SGLT2 Inhibitors
Tags: CoreIM, Primary Care, Endocrinology, Diabetes Mellitus, Type 2 Diabetes, Type 1 Diabetes, Metformin, GLP-1, SGLT2, Insulin, CGM, A1C, DKA, Medical Education, Clinical Reasoning, Hospital Medicine
Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840
Our Sponsors:
* Check out FIGS and use our code FIGSRX for a great deal: https://wearfigs.com
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
